Viewing nowFenopidil Capsules (Fenofibrate Granules (Micronized))
Fenofibrate Granules Micronized 301.95mg
Hard capsule · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

MFDS item code 200300657 · Notified 2003.11.03 · Insurance code 642401580
Treatment of primary hyperlipidemia (hypercholesterolemia, hypertriglyceridemia, etc.)
This medication is effective for primary hyperlipidemia, specifically the combination of hypercholesterolemia and hypertriglyceridemia. It is particularly used for type IIa, IIb, III, and IV hyperlipidemia. This medication helps maintain vascular health by regulating cholesterol and triglyceride levels in the blood. Thus, it contributes to lowering the risk of cardiovascular diseases caused by hyperlipidemia. This medication is used for the improvement and management of hyperlipidemia.
○ Adults: Administer 200 mg of fenofibrate orally once daily immediately after a meal. Fenofibrate must be administered in conjunction with dietary therapy. This medicine may be less well absorbed on an empty stomach, so administer it immediately after a meal (excluding the 145 mg formulation). ○ Elderly patients: Dose reduction is generally not required if renal function is not impaired. ○ Patients with renal impairment: Do not administer this medicine to patients with moderate to severe renal impairment (serum creatinine 2.5 mg/dL or higher).
○ Children: Clinical data on the use of this medicine in children are not yet available.
This medication should not be used in patients with poor liver function. Patients with moderate to severe renal impairment should also avoid this medication due to the risk of rhabdomyolysis, which can cause muscle tissue damage. Pregnant women, women who may become pregnant, and nursing mothers should not take this medication. Patients who have allergic reactions to this medication or its components should not be administered this. Patients with gallbladder diseases or gallstones should be cautious when using this medication due to the risk of gallstone formation. Patients who have experienced photosensitive skin reactions while taking fibrate derivatives or ketoprofen should also avoid this medication. This medication is not administered to children. Patients with biliary cirrhosis or pancreatitis need to be cautious when taking this medication. Patients with mild renal impairment or a history of renal impairment should use this medication carefully by reducing the dose or increasing the interval between doses. Patients with liver function abnormalities or a history of such should be administered this medication carefully while regularly monitoring liver function tests. Patients with hypoalbuminemia, a history of gallstones, those taking anticoagulants, and elderly patients should also be administered this medication cautiously. During administration, various side effects such as liver function abnormalities, skin rashes, muscle pain, gastrointestinal disturbances, and blood abnormalities may occur, so if any abnormal symptoms occur, they should consult a doctor immediately. In particular, if muscle pain or weakness appears, immediate medical attention should be sought due to the possibility of rhabdomyolysis. It is important that this medication is taken with regular blood tests to monitor liver and kidney function. Additionally, since there may be drug interactions, patients should inform their doctor or pharmacist of any other medications they are taking. Pregnant or nursing women should not take this medication, and special care should be taken with children and the elderly. In case of overdose, there is no specific antidote, so it is essential to adhere to the prescribed dosage and administration. This medication should be kept out of reach of children and should not be transferred to other containers for safety.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a sealed container. It is important to keep the storage temperature between 1 degree and 30 degrees Celsius to maintain the medication's effectiveness and safety for a long time.
An orange capsule containing white spherical fine granules
30 capsules/bottle, 200 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowFenofibrate Granules Micronized 301.95mg
Hard capsule · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Fenofibrate Granules Micronized 301.95mg
Hard capsule · Prescription medication
Korea Pharma Co., Ltd.

Fenofibrate Granules Micronized 301.95mg
Hard capsule · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Fenofibrate Granules Micronized 301.95mg
Hard capsule · Prescription medication
Daewoo Pharmaceutical Co., Ltd.

Fenofibrate Granules Micronized 301.95mg
Hard capsule · Prescription medication
Hana Pharmaceutical Co., Ltd.

Fenofibrate Granules Micronized 301.95mg
Hard capsule · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Fenofibrate Granules Micronized 301.95mg
Hard capsule · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Fenofibrate Granules Micronized 301.95mg
Hard capsule · Prescription medication
CMG Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.